Collaboration as the key to turning around the drug discovery business (Part 6) – Technology can make things easier
Science is hard. Drug Discovery is hard. Chemistry is hard. Biology is hard. Business is hard. Innovation is hard. Management is hard.
Technology can make things easier. Some technologies make a little impact. Other technologies, such as the printing press in years past and the linking of computers via the Internet more recently, have a non-linear impact and touch upon nearly all elements of our life. Nearly every experimental result can be improved by an additional insight, perspective, or experiment. This is the basis of scientific progress. What if we could tap into the aggregated, collective, immediate results of all drug discovery scientists worldwide? Can we more optimally balance intellectual property control with the benefit of collective learning? Imagine drug discovery progressing at the speed of the Internet. Imagine the tremendous global human health benefit of easy, simultaneous competition and collaboration. Imagine if we could meaningfully aggregate our collective drug discovery knowledge, efforts, and experiments.
It has been awhile since we posted on this series (see parts 1-5 below, stay tuned for part 7 for more):
P.S. Beyond collaboration as a more enlightened approach to science, here are the top 5 practical reasons collaborative scientists rock with CDD: https://www.collaborativedrug.com/buzz/2011/10/17/5-reasons-why-collaborative-scientists-use-cdd/
You can also download the full series “Collaboration as the key to turning around the drug discovery business” by Barry Bunin as a pdf document: